Article Details
Retrieved on: 2021-07-23 19:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Late last week, the synthetic biology company Synlogic announced data from a Phase 1/2a study of their living biologic designed for the treatment of ...
Article found on: www.genengnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here